1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA DGKG CTRPv2 pan-cancer AAC 0.09 0.01
mRNA ACAP2 CTRPv2 pan-cancer AAC -0.087 0.01
mRNA OR2G2 CTRPv2 pan-cancer AAC -0.084 0.01
mRNA MPZL3 CTRPv2 pan-cancer AAC 0.092 0.01
mRNA TAF9B CTRPv2 pan-cancer AAC -0.089 0.01
mRNA SERPINB12 CTRPv2 pan-cancer AAC 0.084 0.01
mRNA BACE2 CTRPv2 pan-cancer AAC 0.1 0.01
mRNA NXPE4 CTRPv2 pan-cancer AAC -0.085 0.01
mRNA SGK223 CTRPv2 pan-cancer AAC 0.09 0.01
mRNA PTPRZ1 CTRPv2 pan-cancer AAC 0.088 0.01
Download CSV